Time for a Drug Safety Revolution

Join the DRUG SAFETY REVOLUTION

Conventional technology approaches in pharmacovigilance (PV) are obsolete!

Case volumes are increasing and adverse event (AE) sources are expanding, placing tremendous burdens on the industry as they simultaneously struggle with more data, more personalized therapies, and flat or reduced resources. Health authorities, in particular, are met with the greatest challenges, dealing with larger case volumes and more products than any individual manufacturer. With a mandate to ensure the safety of their constituents while providing access to life-saving therapies, health authorities must look for ways to better leverage new technologies to improve efficiency and scale in PV.

Most commercially available PV software is focused on outdated manual processes, and built on inflexible technology that creates barriers to innovation.

Join the drug safety revolution today and learn how the right combination of out-of-the-box PV features and technology platform capabilities support the unique needs of health authorities and enable the delivery of future-proof PV platforms that improve current operations and support future needs.

Pegasystems Inc. understands this dilemma of rigid, old and inflexible PV software and the the need for revolutionizing it.

Join former Former FDA & NIH IT Leader, Milad Bahrami and Ed Chase, Director, Clinical & PV Strategy, Pegasystems on a webinar. on May 23, at 11:00 am EST See how the right combination of out-of-the-box PV features and technology platform capabilities will meet this increasing public health demand. 

A sneak peak of just a few topics you can expect to be covered:

• Out-of-the-box support for FDA data models (NDC, MPID, and UNII), with mapping to WHO Drug Dictionary, synonyms, and custom data sources
• Configurable import and export supporting E2B R2/R3, EMDR, MedWatch, and other formats
• An open, omni-channel platform that configures easily, and integrates seamlessly with existing data sources and new services
• Advanced, configurable duplicate checking, and automated case resolution
• Automated and extensible MedDRA support, with Natural Language Processing (NLP) integration
• Automated, rules-based product labeledness assessment, and integrated risk profile support
• Unique integration with AI-based PV case assessment services for real-time evaluation and confirmation of case assessments
• An intuitive and fully configurable user interface, with advanced workflow, work management, and collaboration features
• Proven, real-world scalability to thousands of users and millions of annual cases 

Register today! 

See you there!

Ferdi Steinmann, Sr Marketing Director, Life Sciences - Pegasystems

PegaWorld 2017: June 4-7 | Las Vegas

Join us to hear how Life Sciences companies are using Pega’s technology to deliver exceptional customer experiences. Learn more